← Leaderboards
Balaji K. Tamarappoo
Cedars-Sinai Medical Center
$1,281,577
Attributed
$2,066,736
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $496.4K · FY2016–23$500K$375K$250K$125K$0
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,066,736 · 2
By mechanism
R01$1,570,318 · 1
R56$496,418 · 1
Top collaborators
- Damini Dey4 shared
Most similar at Cedars-Sinai Medical Center
Same institution · by research overlap
- Kenneth E Bernstein$19,603,058
- James K Min$10,247,587
- Damini Dey$8,447,264
- Piotr J Slomka$14,552,068
- Peter Edic$3,692,210
Others in their field
Top investigators on “Coronary Plaque”
- Steven Kyle Grinspoon · Massachusetts General Hospital$34,010,458
- Pamela Susan Douglas · Duke University$28,087,294
- Shenghan Lai · University Of Miami Coral Gables$21,017,509
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$15,635,642
- Devendra K. Agrawal · Creighton University$13,141,470
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$12,861,357
Research focus
Coronary PlaqueAncillary StudyAdipocytesAngiotensin-Converting Enzyme InhibitorsAngiotensin ReceptorArterial Fatty StreakAngiographyAdipose TissueAtherogenesisAttenuationBlindedCardiacCardiovascular DiseasesCharacteristicsChest PainCholesterolCohortAspirinCoronaryCoronary AngiographyCoronary ArteriosclerosisCoronary ArteryCoronary Computed Tomography AngiographyDensity
Grant awards (5)
Effect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CAD$387,634
R01 · FY2023 · HL
Effect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CAD$383,580
R01 · FY2022 · HL
Effect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CAD$392,515
R01 · FY2021 · HL
Effect of Intensive Medical Treatment on Quantified Coronary Artery Plaque Components with Serial Coronary CTA in Women with Non-Obstructive CAD$406,589
R01 · FY2020 · HL
Detection of vulnerable atherosclerotic plaque with a novel 18F-labeled Integrin targeted PET imaging agent$496,418
R56 · FY2016 · HL · contact PI